A mole becomes cancerous when the pigment-producing cells inside it begin growing uncontrollably, driven by DNA damage that disables the cell’s normal growth brakes. Most moles never make this transition. In a review of over 20,000 melanoma cases, only 29% developed from an existing mole, while 71% appeared as entirely new spots on the skin. Understanding what triggers the shift from harmless mole to melanoma, and how to spot it, can help you catch problems early when they’re most treatable.
What Happens Inside a Cancerous Mole
Normal moles are tidy clusters of melanocytes, the cells that produce the pigment melanin. These cells sit in well-organized nests surrounded by collagen fibers, and they follow the body’s signals to stop dividing when they should. A cancerous mole is one where those signals have broken down.
The key problem is genetic mutation. About 89% of melanomas carry a mutation in one of two genes that control cell growth. Roughly 59% have a mutation in a gene called BRAF, while up to 30% have a mutation in NRAS. These mutations flip on a signaling pathway that tells the cell to keep dividing, and they appear early in the cancer’s development, persisting as the tumor grows and spreads. Once this pathway is stuck in the “on” position, the affected melanocytes begin multiplying without restraint, forming new blood vessels to feed themselves and producing enzymes that break down surrounding tissue to make room for expansion.
At the tissue level, the progression is visible under a microscope. In a normal mole, melanocytes stay neatly at the boundary between the outer skin layer and the deeper layer beneath it. In an atypical mole, those cells start showing variation in the size and shape of their nuclei and form irregular, disorganized clusters. In melanoma, the cells invade upward through all layers of the outer skin and downward into deeper tissue. This spread through multiple skin layers is a hallmark that separates cancer from a merely unusual-looking mole.
How UV Radiation Causes the Damage
Ultraviolet light is the primary environmental trigger that pushes melanocytes toward cancer, but the mechanism is more nuanced than simple sunburn. Research from the Proceedings of the National Academy of Sciences found that melanocytes are uniquely vulnerable to a specific type of UV damage. UVA radiation (the kind that penetrates deeper into skin and passes through windows) generates reactive oxygen species, and melanin itself amplifies this process. Ironically, the very pigment meant to protect your skin makes its own cells more susceptible to oxidative DNA damage.
To make matters worse, melanocytes are poor at repairing this damage compared to other skin cells. When researchers compared melanocytes to ordinary skin fibroblasts, melanocytes accumulated significantly more oxidative DNA damage from the same UVA exposure, while fibroblasts showed little effect. This combination of melanin-boosted damage and reduced repair capacity is what makes melanocytes so prone to accumulating the mutations that lead to cancer. Each episode of UV exposure adds to a growing tally of DNA errors, and eventually one of those errors hits a critical gene like BRAF or NRAS.
The ABCDE Signs to Watch For
The National Cancer Institute uses five visual features to help people identify suspicious moles. These aren’t a diagnosis, but they’re the same warning signs dermatologists use as a starting point.
- Asymmetry: One half of the mole doesn’t match the other. Normal moles tend to be roughly symmetrical.
- Border: The edges are ragged, notched, or blurred rather than smooth. Pigment may spread into the surrounding skin.
- Color: Multiple shades appear within the same mole, including black, brown, tan, white, gray, red, pink, or blue. A single uniform color is more reassuring.
- Diameter: Most melanomas are larger than 6 millimeters (about the size of a pencil eraser), though they can be smaller.
- Evolving: The mole has changed in size, shape, or color over the past few weeks or months. Any visible change in a previously stable mole deserves attention.
Of these five, evolving is often the most useful in practice. A mole that has looked the same for years and suddenly starts changing, itching, or bleeding is more concerning than a large mole that has been stable your entire life.
Atypical Moles Are Not the Same as Cancer
Many people have atypical moles (sometimes called dysplastic nevi) and worry they’re already cancerous. These moles look unusual: they may be larger than normal, have irregular borders, or show uneven color. Under a microscope, their cells show some variation in nuclear size and shape, and their architecture is somewhat disorganized. But they lack the defining feature of melanoma, which is malignant cells invading through multiple layers of skin.
Having atypical moles does increase your overall melanoma risk, particularly if you have many of them or a family history of melanoma. But most atypical moles never become cancer. They sit in a gray zone between perfectly normal and clearly dangerous, which is why dermatologists often monitor them with periodic photos rather than removing every one.
What Dermatologists See That You Can’t
When a dermatologist examines a suspicious mole, they typically use a dermatoscope, a handheld magnifying device with polarized light that reveals structures invisible to the naked eye. The diagnosis of melanoma through this tool rests on recognizing a chaotic, asymmetrical pattern along with specific features: an atypical pigment network, a blue-white veil over part of the lesion, irregular dots or streaks, abnormal blood vessel patterns, or areas where the pigment has regressed and left scar-like white patches.
Dermatologists use scoring systems to formalize what they see. One common approach assigns two points each for an atypical pigment network, a blue-white veil, or abnormal blood vessels, and one point each for irregular streaks, irregular dots, uneven pigmentation, or regression structures. A score of three or more points raises concern for melanoma. Additional signs like a rainbow pattern or surface erosion suggest a more advanced lesion. None of these tools replace a biopsy for a definitive answer, but they help determine which moles warrant one.
Who Faces the Highest Risk
Several factors raise the likelihood that a mole will turn cancerous. Fair skin, light eyes, and red or blond hair all reduce the baseline protection melanin provides. A history of blistering sunburns, especially in childhood, significantly increases lifetime risk. Having more than 50 ordinary moles or more than 5 atypical moles puts you in a higher-risk category. A first-degree relative with melanoma roughly doubles your own risk, partly because mutations affecting the cell growth pathway can be inherited.
Intermittent intense sun exposure (the pattern of office workers who get severe burns on vacation) appears to be more dangerous than steady moderate exposure. Tanning bed use further compounds the risk, delivering concentrated UV radiation directly to the skin. People who are immunosuppressed, whether from medication or illness, also face elevated rates of melanoma because their immune system is less able to detect and destroy abnormal cells before they establish themselves.
Monitoring Your Own Skin
The American Academy of Dermatology recommends performing regular self-exams using a body mole map, where you record the location and appearance of your moles so you can track changes over time. The goal isn’t to diagnose yourself but to notice when something shifts. Pay attention to any spot that is new, changing, itching, or bleeding.
Keep in mind that most melanomas show up as new spots rather than changes in existing moles. This means a thorough self-exam shouldn’t focus only on moles you already know about. Check your entire body, including your scalp, the soles of your feet, between your toes, and under your nails. Use a mirror or ask a partner to help with hard-to-see areas like your back. If something looks off, a dermatologist can evaluate it with tools and expertise that go far beyond what’s possible at home.